New listing in both the Pharmaceutical Schedule Section B and Section H (HML) from 1 November 2017.

Allopurinol–DP Tab 100 mg 500 and Allopurinol–DP Tab 300 mg 500.

Reference pricing to Allopurinol-Apotex Tab 100 mg 1000 Pharmacode 2511878 and Allopurinol-Apotex Tab 300 mg  500 Pharmacode 2511886 will apply from 1 January 2018 with delisting from HML 1 January 2018 and Pharmaceutical Schedule 1 April 2018.

Further information is provided on our website under Pharmac Changes.

As of the date of this notification ProPharma / PWR cannot accept Allopurinol-Apotex Tablets for credit under any circumstances.




About The Author